Netherlands· NL-d6892d609a54

Methergin, oplossing voor injectie 0,2 mg/ml

A methylergometrine product containing methylergometrine waterstofmaleaat, registered in Netherlands by Essential Pharma Limited. The same ATC class is registered in 11 of our 19 countries.

ATC G02AB01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about methylergometrine waterstofmaleaatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Methylergometrine is registered in 11 of 19 countries.

Countries holding a registration under ATC G02AB01 (methylergometrine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search methylergometrine products by name

Methylergometrine · ATC G02AB01

11 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Italyprice
Netherlands
Norwayprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methylergometrine costs, country by country.

Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Methylergometrine · price per daily dose (0.2 mg)

USD · FX 28 Sept 2026

IT Italy$0.19

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: METHYLERGOMETRINE WATERSTOFMALEAAT
Manufacturer: Essential Pharma Limited
Country: Netherlands (NL)
ATC code: G02AB01
ATC class: Methylergometrine
Defined daily dose: 0.2 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
03686

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

138 interactions on record for methylergometrine.

Graded by severity as the source publishes them — 43 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check methylergometrine against other medicines How interaction checks work

Methylergometrine · interactions on record

138 records

43 severe
90 moderate
5 info

Most severe, free to view

EpinephrineA01AD01severe
IsomethepteneA03AX10severe
LorcaserinA08AA11severe
PhenylpropanolaminA08AA13severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methylergometrine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylergometrine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

Belgium · Methergin
Bulgaria · Methergin, Метергин
Germany · Methergin, Methergin®
Denmark · Methergin
Spain · Methergin, Methergín
France · Methergin
Greece · Demergin
Iceland · Methergin
Italy · Methergin
Luxembourg · Methergin
Sweden · Methergin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/cf01d6da-b509-46bc-b8a2-b1a5194c07d5
GET /v1/drugs/cf01d6da-b509-46bc-b8a2-b1a5194c07d5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intramusculair gebruik, Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h03686_smpc.pdf",
  "strength": null,
  "atc_label": "Methylergometrine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg03686",
  "excipients": [
    "KOOLSTOFDIOXIDE, HEAD SPACE (E 290)",
    "MALEÏNEZUUR",
    "NATRIUMCHLORIDE",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "METHYLERGOMETRINE WATERSTOFMALEAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h03686.pdf",
  "authorised_at": "1990/05/20",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "03686",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about methylergometrine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console